New Drugs in Colorectal Cancer: A Review of Antitumor Activity and Cross-Resistance Patterns of Topoisomerase I Inhibitors, Thymidylate Synthetase Inhibitors, and Oxaliplatin

Publisher： Karger

E-ISSN： 2296-5262|21|2|95-103

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.2, 1998-05, pp. : 95-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New Advances in Lung Cancer Chemotherapy: Topotecan and the Role of Topoisomerase I Inhibitors

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 14-24

Karger

Access to resources Recommend Favorite

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1397-1405

John Wiley & Sons Inc

Access to resources Recommend Favorite

PKC/MEK inhibitors suppress oxaliplatin‐induced neuropathy and potentiate the antitumor effects

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer

By  

Current Signal Transduction Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 234-243

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Cross-Resistance Between Paclitaxel and Docetaxel for Metastatic Gastric Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 4, 2012-03 ,pp. : 176-183

Karger

Access to resources Recommend Favorite